Osi Pharmaceuticals, Inc.

Other

Li Qiu

Andrew Philip Crew

Arlindo Lucas Castelhano

An-Hu Li

Tao Zhang

Han-Qing Dong

Colin Peter Sambrook Smith

Hanqing Dong

Alun Smith

Ayako Honda

Kristen Michelle Mulvihill

Graham Wynne

Joshua Bolger

Lawrence Tardibono

Yingchaun Sun

Compounds represented by Formula (I): or a pharmaceutically acceptable salt or N-oxide thereof, wherein A, Q, Y, R, m and J are defined herein, are useful in the treatment of tumors and cancers such as mastocytosis/mast cell leukemia, gastrointestinal stromal tumors (GIST), germ cell tumors, small cell lung carcinoma (SCLC), sinonasal natural killer/T-cell lymphoma, testicular cancer (seminoma), thyroid carcinoma, malignant melanoma, ovarian carcinoma, adenoid cystic carcinoma, acute myelogenous leukemia (AML), breast carcinoma, pediatric T-cell acute lymphoblastic leukemia, neuroblastoma, mast cell leukemia, angiosarcoma, anaplastic large cell lymphoma, endometrial carcinoma, and prostate carcinoma.

(Arylamidoaryl)squaramide compounds

Compounds represented by Formula (I): or a pharmaceutically acceptable salt or N-Oxide thereof, are useful in the treatment of cancer.

N-substituted imidazopyridine c-Kit inhibitors

Compounds represented by Formula (I): or a pharmaceutically acceptable salt or N-oxide thereof, are useful in the treatment of cancer.

N-substituted benzimidazolyl c-Kit inhibitors

N3-substituted imidazopyridine c-Kit inhibitors

Compounds represented by Formula (I): or a pharmaceutically acceptable salt or N-oxide thereof, wherein A, Q, Y, Rand J are defined herein, are useful in the treatment of cancer.

(Arylamidoaryl) cyanoguanidine compounds

Growing community of inventors

Farmingdale, NY, United States of America

Li Qiu